Skip to main content
. 2022 Jun 13;55(4):321–333. doi: 10.3961/jpmph.21.640

Table 2.

Pooled summary for the association of comorbidities with COVID-19 infection

Comorbidity No. of included studies/total studies Group n/N OR (95% CI) p-value 95% prediction interval


COVID-19 positive COVID-19 negative UL LL
Underweight 1/16 2/449 1759/348 149 0.88 (0.22, 3.54) 0.858 - -

Overweight 2/16 272/650 148 610/348 350 1.58 (0.65, 3.86) 0.314 - -

Obesity 1/16 158/449 82 770/348 149 1.74 (1.43, 2.11) <0.001 - -

Diabetes 8/16 1013/3308 331 477/358 939 1.14 (0.72, 1.82) 0.579 0.23 5.74

Hypertension 7/16 1045/2859 3615/10 826 0.99 (0.70, 1.43) 0.982 0.32 3.12

High cholesterol 2/16 510/2246 1851/10 209 0.95 (0.56, 1.63) 0.780 0.02 46.65

Cardiovascular disease 4/16 60/550 47/416 1.20 (0.39, 3.72) 0.754 0.01 159.25

Depression 1/16 73/782 141/7025 0.96 (0.56, 1.63) 0.866 - -

Schizophrenia 1/16 15/782 427/7025 0.56 (0.37, 0.82) 0.003 - -

Dementia 1/16 27/782 1172/7025 0.56 (0.43, 0.71) <0.001 - -

Coronary artery disease 2/16 77/847 946/7090 0.64 (0.46, 0.87) 0.005 - -

Chronic lung disorder 4/16 272/1245 1920/7488 1.26 (0.99, 1.61) 0.055 0.63 2.54

Townsend deprivation quintile
 1 1/16 61/449 70 726/348 149 0.62 (0.47, 0.81) <0.001 - -
 2 1/16 76/449 70 644/348 149 0.80 (0.62, 1.02) 0.075 - -
 3 1/16 64/449 70 270/348 149 0.65 (0.50, 0.85) 0.002 - -
 4 1/16 105/449 65 840/348 149 1.21 (0.97, 1.50) 0.092 - -
 5 1/16 143/449 65 840/348 149 2.00 (1.64, 2.44) <0.001 - -

COVID-19, coronavirus disease 2019; n, number of patients with the comorbidity; N, total patients in the group; OR, odds ratio; CI, confidence interval.